N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
Patent Information
- Authority / Receiving Office
- US · United States
- Current Assignee / Owner
- INCYTE
- Publication Date
- 2008-05-29
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. Ser. No. 60 / 845,700, filed Sep. 19, 2006, the disclosure of which is incorporated herein by reference in its entirety.FIELD OF THE INVENTION
[0002] The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.BACKGROUND OF THE INVENTION
[0003] Tryptophan (Trp) is an essential amino acid required for the biosynthesis of proteins, niacin and the neurotransmitter 5-hydroxytryptamine (serotonin). The enzyme indoleamine 2,3-dioxygenase (also known as INDO or IDO) catalyzes the first and rate limiting step in the degradation of L-tryptophan to N-formyl-kynurenine. In human cells, a depletion of Trp resulting from IDO activity is a prominent gamma interferon (IFN-γ)-inducible antimicrobial effector mechanism. IFN-γ stimulation induces activation of IDO, which leads to a depletion of Trp, thereby arresting the growth of Trp-...